These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 2452418

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
    Estes NA, Gold R, Cameron J, Haffajee C, Marshall M, Mack K, Salem DN.
    Am J Cardiol; 1987 Jun 15; 59(16):20H-26H. PubMed ID: 3591711
    [Abstract] [Full Text] [Related]

  • 3. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT, Nademanee K, Antimisiaris M, Pacifico A, Pruitt C, Godfrey R, Singh BN.
    Circulation; 1993 Sep 15; 88(3):1072-82. PubMed ID: 8353869
    [Abstract] [Full Text] [Related]

  • 4. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia.
    Miura DS, Schwartz J, Laux B, Wynn J, Keefe D, Somberg JC.
    J Clin Pharmacol; 1987 Jul 15; 27(7):481-6. PubMed ID: 3654999
    [Abstract] [Full Text] [Related]

  • 5. Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery disease.
    Easley AR, Mann DE, Reiter MJ, Sakun V, Sullivan SM, Magro SA, Luck JC, Wyndham CR.
    Am J Cardiol; 1986 Jul 01; 58(1):86-9. PubMed ID: 3728337
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Electrophysiology and antiarrhythmic efficacy of intravenous pirmenol in patients with sustained ventricular tachyarrhythmias.
    Liem LB, Clay DA, Franz MR, Swerdlow CD.
    Am Heart J; 1987 Jun 01; 113(6):1390-6. PubMed ID: 3591608
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical pharmacology and pharmacokinetics of pirmenol.
    Reiter MJ.
    Angiology; 1988 Mar 01; 39(3 Pt 2):293-8. PubMed ID: 3281518
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antiarrhythmic effects of cibenzoline.
    Miura DS, Keren G, Torres V, Butler B, Aogaichi K, Somberg JC.
    Am Heart J; 1985 Apr 01; 109(4):827-33. PubMed ID: 3984837
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation.
    Doherty JU, Waxman HL, Kienzle MG, Cassidy DM, Marchlinski FE, Buxton AE, Josephson ME.
    J Am Coll Cardiol; 1984 Aug 01; 4(2):378-81. PubMed ID: 6736479
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti-arrhythmic efficacy of nifekalant hydrochloride, a pure class III anti-arrhythmic agent, in patients with healed myocardial infarction and inducible sustained ventricular tachycardia.
    Igawa M, Aonuma K, Okamoto Y, Hiroe M, Hiraoka M, Isobe M.
    J Cardiovasc Pharmacol; 2002 Nov 01; 40(5):735-42. PubMed ID: 12409982
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.